Cerebrospinal beta-amyloid (1–42) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline

Clinical diagnosis of Alzheimer's disease

1984 • 27,279 citations

Frontotemporal lobar degeneration

1998 • 4,937 citations

Vascular dementia

1993 • 4,707 citations

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

1993 • 1,480 citations

Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions

1993 • 1,092 citations

Improved discrimination of AD patients using β-amyloid _(1-42) and tau levels in CSF

1999 • 709 citations

Reduction of β‐amyloid peptide₄₂ in the cerebrospinal fluid of patients with Alzheimer's disease

1995 • 684 citations

Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease

1999 • 631 citations

High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype

1998 • 445 citations

Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

1999 • 244 citations

Cerebrospinal fluid A?42 is increased early in sporadic Alzheimer's disease and declines with disease progression

1999 • 215 citations

Development of a Specific Diagnostic Test for Measurement of β-Amyloid (1-42) [βA4(l-42)] in CSF

1998 • 70 citations

CSF beta-amyloid, cognition, and APOE genotype in Alzheimer’s disease

1999 • 68 citations

Alzheimer’s and Parkinson’s Disease

1986 • 67 citations

Alzheimer’s and Parkinson’s Diseases

1995 • 66 citations

Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's disease

1998 • 32 citations